1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA OR4E2 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA TK1 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA TXNL4A CTRPv2 pan-cancer AAC 0.11 0.001
mRNA LMNA CTRPv2 pan-cancer AAC -0.13 0.001
mRNA NAIP CTRPv2 pan-cancer AAC 0.11 0.001
mRNA NBPF19 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA TAOK1 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA WIF1 CTRPv2 pan-cancer AAC 0.1 0.001
mRNA FNDC9 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA CXADR CTRPv2 pan-cancer AAC 0.12 0.001
Download CSV